We recently compiled a list of the 12 Best Big Name Stocks to Invest in Now. In this article, we are going to take a look at ...

The week's investing action plan includes a strong dose of pharma and biotech earnings, January econ reports, plus Amazon and ...

Stocks rose on Thursday, posting gains in a bout of rocky trading as investors weighed the latest earnings from Big Tech companies. Stocks cut gains late in the session after President Donald Trump ...

Plymouth Industrial REIT, Inc. (NYSE:PLYM – Get Free Report) has been assigned an average rating of “Hold” from the nine brokerages that are covering the firm, Ratings reports. One investment analyst ...

Nasdaq 100 futures rose Monday night. The action followed a sell-off fueled by worries over the emergence of Chinese startup ...

Major stock indexes weren't moving much in the stock market today, but there were plenty of big gainers below the surface.

The Dow Jones rallied on the stock market today. A Donald Trump stock dived while Cathie Wood snapped up a plunging AI stock.

2024 was an excellent year for the major stock market indexes. But the Dow Jones Industrial Average ( ^DJI 0.78%) had just a ...

The Dow Jones Industrial Average (DJIA) rose sharply ... This process ensures the integrity, relevance, and value of our content for our readers. Lilly Mwogah is a finance writer specializing in ...

For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. Eli Lilly said it received Food and Drug Administration approval ...

Oil futures resume their rally with winter demand and prospects of supply curbs due to U.S. sanctions pushing prices to their highest level since August. "U.S. sanctions against Russia remain the ...

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn's disease, an inflammatory bowel disease that causes chronic abdominal pain.